Post-earnings recap
Reported
Thu, Jul 16, 2026
EPS actual
$1.31
EPS est.
$1.28
EPS surprise
+2.66%
1-day move
+10.71%
Abbott Laboratories reported better-than-expected earnings per share, which contributed to a significant stock increase of 10.71%. The positive EPS surprise indicates stronger profitability than analysts anticipated. However, revenue figures were not disclosed, leaving some uncertainty about overall sales performance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.31 | $1.28 | +2.66% |
| Revenue | — | $12.5B | — |
No transcript is on record, and the analysis is based solely on numerical results.
Abbott Laboratories (ABT) is a global health care company that develops and manufactures a wide range of medical devices, diagnostics, and nutritional products. With a market cap of $193 billion, Abbott plays a crucial role in the health care sector, particularly in areas like diabetes care and cardiovascular health.
Last quarter
In Q1-2026, Abbott reported an EPS of $1.15, slightly beating estimates, but the stock fell by 6% the next day. The company has consistently surprised analysts with positive EPS results over the past quarters.
EPS beat streak
8Q
EPS beat rate
100%
Avg EPS surprise
+0.94%
Avg 1-day reaction
-1.45%
Analysts expect Abbott to report solid earnings this quarter, with a consensus EPS of $1.28 and revenue of $12.5 billion. The market is closely watching how the company navigates ongoing challenges in the health care sector.
Bull case
If Abbott exceeds EPS and revenue expectations, it could signal strong demand for its products and effective cost management, potentially boosting investor confidence.
Bear case
Conversely, if Abbott falls short of expectations, it may raise concerns about market demand and operational challenges, leading to a negative reaction in the stock.
Key metrics to watch
EPS
$1.28Earnings per share is a key indicator of profitability and will show how well Abbott is managing its costs and revenues.
Revenue
$12.5BTotal revenue reflects the overall sales performance and demand for Abbott's products, which is critical for assessing growth.
The print will turn on these.
Q1
Will Abbott's revenue exceed the $12.5 billion consensus estimate?
Revenue is a critical indicator of demand for Abbott's products, and exceeding expectations could signal strong market performance.
Q2
How will management address recent operational challenges?
Investors will be keen to hear management's insights on navigating current market conditions and any strategies to enhance profitability.
—
Est. EPS
$1.15
Est. Rev
$178M
Impl. Move
±7.1%
Why consensus could be wrong
The Street may be underestimating the potential for Abbott to exceed revenue expectations due to strong demand in its diabetes care segment, which has shown resilience.
Supporting evidence
Abbott has consistently surprised on EPS, indicating strong operational management.
Options pricing suggests a significant move, indicating that the market is bracing for potential surprises.
Key risk
If revenue comes in below $12.3 billion, it could undermine the positive sentiment around Abbott's growth prospects.
Pre-commit to what would confirm each case.
The core debate this quarter revolves around Abbott's ability to sustain growth and manage costs effectively amidst market challenges.
Bull confirmed if
An EPS of $1.30 or higher would confirm strong operational performance and investor confidence.
Bear confirmed if
An EPS below $1.26 would raise concerns about Abbott's ability to maintain profitability in a competitive market.
What the market is pricing for the move.
Implied Move
±8.67%
Historical Avg
±5.4%
The options market is pricing in a significant move around the earnings report, indicating uncertainty about the results.
Options are pricing ±8.7% while ABT has averaged ±5.4% over the last 8 prints — setup is pricing rich.
ATM IV
0.3%
30d HV
26.1%
Cross-company pattern from 30 similar setups.
Prior-quarter beat + options rich in Health Care
Fade rate: 13 of 29 (45%)
This setup has occurred 30 times across Health Care in the last 2 years. 13 of 29 faded and 16 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 5.5%, with a raw directional average of +2.9% (modestly positive historical bias).
Smart-money positioning from the most recent 13F filings.
Institutional
81.79%
of float
Insider
0.49%
of float
Holders
3,782
institutions
Top Holders· as of Jun 2026
Blackrock Inc.
152,563,476 sh · $15.1B
8.82%
4.7%
Likely market behavior by outcome. Not investment advice.
Beat & raise
If Abbott beats expectations, history suggests a potential average one-day move of +3.34%, confirming strong operational performance.
In line / cautious
If results are in line with expectations, the stock may experience muted movement as the market digests management's commentary.
Miss
A miss could lead to a decline, with history suggesting an average one-day drop of around -3.34%.
House and Senate STOCK Act disclosures over the trailing 6 months.
Trades
9
2 buys·7 sells
Members
7
House only
Est. Notional
$23,009.00–$170,000.00
disclosed dollar ranges
Most Active Members
2 trades
The lines on the call that would change the story.
Vanguard Capital Management LLC
113,750,994 sh · $11.2B
6.57%
0.7%
State Street Corporation
80,926,234 sh · $8.0B
4.68%
1.7%
Charles Schwab Investment Management, Inc.
59,674,507 sh · $5.9B
3.45%
31.1%
Vanguard Portfolio Management LLC
49,017,866 sh · $4.8B
2.83%
2.2%
13F filings updated quarterly. Position deltas show change in shares vs. the prior quarter.
Mixed
2 trades
Mixed
1 trade
Net selling
1 trade
Net selling
Recent Transactions
Traded Jul 30, 2026 · disclosed Aug 14, 2026
$1,001.00–$15,000.00
Traded Jul 17, 2026 · disclosed Aug 12, 2026
$1,001.00–$15,000.00
Traded Jul 14, 2026 · disclosed Aug 18, 2026
$15,001.00–$50,000.00
Traded Jul 8, 2026 · disclosed Jul 12, 2026
$1,001.00–$15,000.00
Traded Jun 16, 2026 · disclosed Jul 2, 2026
$1,001.00–$15,000.00
Filed 30–45+ days after the trade. Treat as positional context, not a leading indicator. Amounts are SEC-mandated dollar ranges, not exact values.